The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Recommended diagnostic criteria for paraneoplastic neurological syndromes
Open accessAbstract
The entopeduncular nucleus (EPN) and substantia nigra pars reticulata (SNr) constitute the output nuclei of the basal ganglia, but studies on the EPN are limited compared with those on the SNr. Both nuclei receive projections from the striatum with axons containing substance P (SP) and cannabinoid type-1 receptor (CB1R), and immunoreactivities for these substances show complementary patterns in the striatum and SNr. In this study we revealed a similar complementarity in the mouse EPN, combined it with region-specific neuronal distributions, and defined subregions of the EPN. First, the EPN was divided into two areas, one showing low SP and high CB1R (lSP/hCB1R) immunoreactivities and the other showing opposite immunoreactivities (hSP/lCB1R). The former received inputs from the dorsolateral striatum that is innervated by sensorimotor cortices, whereas the latter received inputs from the medial striatum innervated by limbic/association cortices. Then, the lSP/hCB1R area was further divided into the dorsolateral subregion in the rostral EPN and the core subregion in the caudal EPN, the latter characterized by the concentration of parvalbumin-positive neurons targeting the VA-VL thalamic nucleus. The hSP/lCB1R area was divided into the ventromedial subregion in the rostral EPN and the shell subregion in the caudal EPN, the former characterized by the concentration of nitric oxide synthase-positive neurons targeting the lateral habenula (LHb). Somatostatin-positive neurons targeting the LHb were located diffusely in three subregions other than the core. These findings illuminate structural organization inside the basal ganglia, suggesting mechanisms for sorting diverse information through parallel loops with differing synaptic modulation by CB1R. Significance statement The entopeduncular nucleus (EPN) in rodents corresponds to the internal segment of the globus pallidus in primates and is one of the major output nuclei of the basal ganglia. Because studies on the EPN are limited, we investigated the morphological features of the mouse EPN, focusing on the complementary immunoreactivities for substance P (SP) and cannabinoid type-1 receptor (CB1R). The EPN was first divided into two parts, one showing low SP and high CB1R immunoreactivities and the other showing opposite immunoreactivities. Each part was further divided into two subregions based on the distributions of different neuronal types. The present findings clarify the structural organization inside the EPN, suggesting mechanisms for processing diverse information with differing synaptic modulation by CB1R.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gultekin, S. H. (2000) · Brain · doi:10.1093/brain/123.7.1481 · Cited by 1,123
Paraneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Vincent, A., Buckley, C., Schott, J. M., Baker, I., Dewar, B., Detert, N., Clover, L., Parkinson, A., Bien, C. G., Omer, S., et al. (2004) · Brain · doi:10.1093/brain/awh077 · Cited by 1,038
A COMPUTER-ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS
BOHAN, A., PETER, J. B., BOWMAN, R. L., & PEARSON, C. M. (1977) · Medicine · doi:10.1097/00005792-197707000-00001 · Cited by 1,024
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
Graus, F. (2001) · Brain · doi:10.1093/brain/124.6.1138 · Cited by 897
Self-citationTHE LAMBERT-EATON MYASTHENIC SYNDROME: A REVIEW OF 50 CASES
O'NEILL, J. H., MURRAY, N. M. F., & NEWSOM-DAVIS, J. (1988) · Brain · doi:10.1093/brain/111.3.577 · Cited by 686
MD, K. P., Rosenblum, M. K., MS, H. K., & Posner, J. B. (1992) · Neurology · doi:10.1212/wnl.42.10.1931 · Cited by 608
Shams’ili, S., Grefkens, J., de Leeuw, B., van den Bent, M., Hooijkaas, H., van der Holt, B., Vecht, C., & Sillevis Smitt, P. (2003) · Brain · doi:10.1093/brain/awg133 · Cited by 579
Paraneoplastic Cerebellar Ataxia Due to Autoantibodies against a Glutamate Receptor
Smitt, P. S., Kinoshita, A., De Leeuw, B., Moll, W., Coesmans, M., Jaarsma, D., Henzen-Logmans, S., Vecht, C., De Zeeuw, C., Sekiyama, N., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001063420104 · Cited by 451
Graus, F., Dalmou, J., Reñé, R., Tora, M., Malats, N., Verschuuren, J. J., Cardenal, F., Viñolas, N., Garcia del Muro, J., Vadell, C., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2866 · Cited by 378
Self-citation
Cited by
A clinical approach to diagnosis of autoimmune encephalitis
Graus, F., Titulaer, M. J., Balu, R., Benseler, S., Bien, C. G., Cellucci, T., Cortese, I., Dale, R. C., Gelfand, J. M., Geschwind, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00401-9 · Cited by 4,516
Self-citationClinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
Dalmau, J., Lancaster, E., Martinez-Hernandez, E., Rosenfeld, M. R., & Balice-Gordon, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70253-2 · Cited by 2,435
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents
Florance, N. R., Davis, R. L., Lam, C., Szperka, C., Zhou, L., Ahmad, S., Campen, C. J., Moss, H., Peter, N., Gleichman, A. J., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21756 · Cited by 1,090
“Based on the experience with some adults whose initial teratoma or second teratoma was identified many months after the first episode of encephalitis or at a relapse,(2) periodic MRI or ultrasound studies for at least 2 years appears prudent.(15) At this time, the number of male patients is too small for recommendatio…”
Self-citationParaneoplastic Syndromes Involving the Nervous System
Darnell, R. B., & Posner, J. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023009 · Cited by 1,062
Paraneoplastic syndromes of the CNS
Dalmau, J., & Rosenfeld, M. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70060-7 · Cited by 873
Schwartz, J., Padmanabhan, A., Aqui, N., Balogun, R. A., Connelly‐Smith, L., Delaney, M., Dunbar, N. M., Witt, V., Wu, Y., & Shaz, B. H. (2016) · Journal of Clinical Apheresis · doi:10.1002/jca.21470 · Cited by 793
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment
Pelosof, L. C., & Gerber, D. E. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0099 · Cited by 773
Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
Graus, F., Vogrig, A., Muñiz-Castrillo, S., Antoine, J.-C. G., Desestret, V., Dubey, D., Giometto, B., Irani, S. R., Joubert, B., Leypoldt, F., et al. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000001014 · Cited by 759
Self-citationAnti-LGI1 encephalitis: Clinical syndrome and long-term follow-up
van Sonderen, A., Thijs, R. D., Coenders, E. C., Jiskoot, L. C., Sanchez, E., de Bruijn, M. A. A. M., van Coevorden-Hameete, M. H., Wirtz, P. W., Schreurs, M. W. J., Sillevis Smitt, P. A. E., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000003173 · Cited by 658
Dalmau, J., Geis, C., & Graus, F. (2017) · Physiological Reviews · doi:10.1152/physrev.00010.2016 · Cited by 628
Self-citationSaiz, A., Blanco, Y., Sabater, L., González, F., Bataller, L., Casamitjana, R., Ramió-Torrentà, L., & Graus, F. (2008) · Brain · doi:10.1093/brain/awn183 · Cited by 623
Self-citationSchwartz, J., Winters, J. L., Padmanabhan, A., Balogun, R. A., Delaney, M., Linenberger, M. L., Szczepiorkowski, Z. M., Williams, M. E., Wu, Y., & Shaz, B. H. (2013) · Journal of Clinical Apheresis · doi:10.1002/jca.21276 · Cited by 603
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Titulaer, M. J., Soffietti, R., Dalmau, J., Gilhus, N. E., Giometto, B., Graus, F., Grisold, W., Honnorat, J., Sillevis Smitt, P. A. E., Tanasescu, R., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03220.x · Cited by 526
Self-citationAntibodies to glutamic acid decarboxylase define a form of limbic encephalitis
Malter, M. P., Helmstaedter, C., Urbach, H., Vincent, A., & Bien, C. G. (2010) · Annals of Neurology · doi:10.1002/ana.21917 · Cited by 514
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
Lancaster, E., & Dalmau, J. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.99 · Cited by 512
Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Tüzün, E., & Dalmau, J. (2007) · The Neurologist · doi:10.1097/nrl.0b013e31813e34a5 · Cited by 478
Irani, S. R., Stagg, C. J., Schott, J. M., Rosenthal, C. R., Schneider, S. A., Pettingill, P., Pettingill, R., Waters, P., Thomas, A., Voets, N. L., et al. (2013) · Brain · doi:10.1093/brain/awt212 · Cited by 437
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Lancaster, E., Martinez-Hernandez, E., & Dalmau, J. (2011) · Neurology · doi:10.1212/wnl.0b013e318224afde · Cited by 403
Antibodies and neuronal autoimmune disorders of the CNS
Graus, F., Saiz, A., & Dalmau, J. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5431-9 · Cited by 392
Self-citationParaneoplastic Neurologic Syndrome in the PNS Euronetwork Database: A European Study From 20 Centers
Giometto, B. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.341 · Cited by 373
Paraneoplastic neurological syndromes
Honnorat, J., & Antoine, J.-C. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-22 · Cited by 357
Zuliani, L., Graus, F., Giometto, B., Bien, C., & Vincent, A. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301237 · Cited by 293
Self-citationParaneoplastic neurological syndromes in the era of immune-checkpoint inhibitors
Graus, F., & Dalmau, J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0194-4 · Cited by 276
Self-citationHonnorat, J., Cartalat-Carel, S., Ricard, D., Camdessanche, J. P., Carpentier, A. F., Rogemond, V, Chapuis, F., Aguera, M., Decullier, E., Duchemin, A. M., et al. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.138016 · Cited by 272
Self-citationGABA B receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders
Boronat, A., Sabater, L., Saiz, A., Dalmau, J., & Graus, F. (2011) · Neurology · doi:10.1212/wnl.0b013e31820e7b8d · Cited by 271
Self-citationThe pattern and diagnostic criteria of sensory neuronopathy: a case-control study
Camdessanche, J.-P., Jousserand, G., Ferraud, K., Vial, C., Petiot, P., Honnorat, J., & Antoine, J.-C. (2009) · Brain · doi:10.1093/brain/awp136 · Cited by 262
Psychiatric Manifestations of Paraneoplastic Disorders
Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129
Paraneoplastic neuropathy: wide-ranging clinicopathological manifestations
Koike, H., Tanaka, F., & Sobue, G. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834a87b7 · Cited by 105
Tannoury, J., de Mestier, L., Hentic, O., Ruszniewski, P., Créange, A., & Sobhani, I. (2021) · Neuroendocrinology · doi:10.1159/000506400 · Cited by 4
Metadata
- Authors
- Graus, F.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 2004-08-01
- Volume
- 75
- Issue
- 8
- Pages
- 1135-1140
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2099917041
- Cited by
- 1,610
- References
- 38
- FWCI
- 28.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.